Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $3.00 and last traded at $4.90, with a volume of 5643 shares changing hands. The stock had previously closed at $4.85.
Analyst Ratings Changes
Separately, Wall Street Zen initiated coverage on Veradigm in a research report on Tuesday, May 20th. They set a "hold" rating on the stock. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Veradigm has an average rating of "Hold" and a consensus price target of $13.00.
Get Our Latest Research Report on Veradigm
Veradigm Price Performance
The company has a 50-day simple moving average of $4.74 and a two-hundred day simple moving average of $4.60.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.